Test Price
2,800 AED✅ Home Collection Available
CLN5 Gene Neuronal Ceroid Lipofuscinosis Type 5 Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next‑Generation Sequencing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHCC‑licensed clinicians.
Price: 2,800 AED (inclusive of genetic counseling report).
Turnaround Time: 3–4 weeks from sample receipt.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CLN5 gene test screens for pathogenic variants causing Neuronal Ceroid Lipofuscinosis type 5 (CLN5 disease), a rare neurodegenerative lysosomal storage disorder. This NGS‑based test provides comprehensive mutation analysis with industry‑leading accuracy, ensuring early diagnosis and family counseling.
| Feature | Our CLN5 NGS Test (ISO‑Certified) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Sanger sequencing – limited to hotspot regions |
| Diagnostic Sensitivity | >99.9% | ~95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2,800 AED | 1,500–2,000 AED (incomplete coverage) |
| Regulatory Compliance | DHA/MOHAP, ISO 9001:2015, UAE PDPL | Variable |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) – “CLN5 gene testing must be correlated with neurological and ophthalmological findings; a positive result confirms the diagnosis but does not predict the rate of progression. A negative result does not rule out other neuronal ceroid lipofuscinosis subtypes or metabolic disorders. Always discuss results with your treating neurologist or genetic counselor before making any clinical decisions.”
⚠ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are not a substitute for ongoing clinical management.
🚨 Exclusion Criteria & Emergency Red Flags
- Exclusion: Testing of minors without parental consent (Federal Decree‑Law No. 4 of 2016 on Medical Liability, Art. 12); patients without clinical suspicion or family history of CLN5‑related disease; samples collected outside validated cold‑chain conditions.
- ER Red Flags: Sudden vision loss, unexplained seizures, rapid developmental regression, or loss of ambulation – seek emergency medical attention immediately.
Patient FAQ & Clinical Guidance
1. What is the CLN5 gene test and why is it performed?
The CLN5 gene test uses Next‑Generation Sequencing to detect pathogenic variants causing neuronal ceroid lipofuscinosis type 5, a rare inherited neurodegenerative disorder. It enables accurate diagnosis, prognosis assessment, and informed family planning.
2. How is the sample collected and what is the turnaround time?
A simple blood draw is collected via our VIP Mobile Phlebotomy team under temperature‑controlled cold‑chain conditions. Results are delivered within 3–4 weeks from sample receipt.
3. Is home collection available and how do I book?
Yes, our mobile phlebotomy service covers all emirates of the UAE. Book directly via WhatsApp +971 54 548 8731 – available daily 8 AM to 11 PM.
4. What do the results mean for my family?
A positive result indicates a genetic diagnosis of CLN5 disease. This may have implications for siblings and other relatives. Genetic counseling is provided to discuss recurrence risks and carrier testing options.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License 1143.
Clinical & Logistical Metadata
| Test Name | CLN5 Gene Sequencing (Neuronal Ceroid Lipofuscinosis Type 5) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Coding Region & Intron‑Exon Boundaries |
| ICD-10-CM Code | E75.4 (Neuronal ceroid lipofuscinosis) |
| LOINC Code | 94220-4 (CLN5 gene mutation analysis in Blood or Tissue by NGS) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians